Abstract:Background: The disorder of uric acid metabolism is closely associated with gut microbiota and short-chain fatty acids (SCFAs) dysregulation, but the biological mechanism is unclear, limiting the development of uric acid-lowering active polysaccharides. Konjac glucomannan (KGM) could attenuate metabolic disturbance of uric acid and modulate the gut microbiota. However, the relationship between uric acid metabolism and gut microbiota is still unknown. Methods: In this study, The fecal samples were provided by healthy volunteers and hyperuricemia (HUA) patients. Fecal samples from healthy volunteers was regarded as the NOR group. Similarly, 10% HUA fecal suspension was named as the HUA group. Then, fecal supernatant was inoculated into a growth basal medium containing glucose or KGM, and healthy fecal samples were designated as the NOR-GLU and NOR-KGM groups, while HUA fecal samples were designated as the HUA-GLU and HUA-KGM groups. All samples were cultured in an anaerobic bag system. After fermentation for 24 h, the samples were collected for further analysis of composition of intestinal microbiota, SCFAs concentration and XOD enzyme activity. Results: The results showed that KGM could be utilized and degraded by the gut microbiota from HUA subjects, and it could modulate the composition and structure of their HUA gut microbiota to more closely resemble that of a healthy group. In addition, KGM showed a superior modulated effect on HUA gut microbiota by increasing Megasphaera, Faecalibacterium, Lachnoclostridium, Lachnospiraceae, Anaerostipes, and Ruminococcus levels and decreasing Butyricicoccus, Eisenbergiella, and Enterococcus levels. Furthermore, the fermentation solution of KGM showed an inhibitory effect on xanthine oxidase (XOD) enzyme activity, which might be due to metabolites such as SCFAs. Conclusion: In conclusion, the effect of KGM on hyperuricemia subjects was investigated based on the gut microbiota in vitro. In the present study. It was found that KGM could be metabolized into SCFAs by HUA gut microbiota. Furthermore, KGM could modulate the structure of HUA gut microbiota. At the genus level, KGM could decrease the relative abundances of Butyricicoccus, Eisenbergiella, and Enterococcus, while Lachnoclostridium and Lachnospiraceae in HUA gut microbiota were significantly increased by the addition of KGM. The metabolites of gut microbiota, such as SCFAs, might be responsible for the inhibition of XOD activity. Thus, KGM exhibited a superior probiotic function on the HUA gut microbiota, which is expected as a promising candidate for remodeling the HUA gut microbiota.

Effect of Partially Hydrolyzed Guar Gum on the Composition and Metabolic Function of the Intestinal Flora of Healthy Mice.

Study on the ability of partially hydrolyzed guar gum to modulate the gut microbiota and relieve constipation

Simulated Gastrointestinal Digestion of Yak Bone Collagen Hydrolysates and Insights into Its Effects on Gut Microbiota Composition in Mice

Possible Beneficial Effects of Xyloglucan from Its Degradation by Gut Microbiota

Studies of Peach Gum Polysaccharide on Gut Microbiota in Vitro Fermentation by Human Feces

Effects of Zymosan on Short-Chain Fatty Acid and Gas Production in in vitro Fermentation Models of the Human Intestinal Microbiota

Properties of Hydrolyzed Guar Gum Fermented in Vitro with Pig Fecal Inocula and Its Favorable Impacts on Microbiota.

Partially Hydrolyzed Guar Gum Attenuates D-Galactose-Induced Oxidative Stress And Restores Gut Microbiota In Rats

The Effect of Voluntary Exercise on Gut Microbiota in Partially Hydrolyzed Guar Gum Intake Mice under High-Fat Diet Feeding

Effect of Functional Oligosaccharides and Ordinary Dietary Fiber on Intestinal Microbiota Diversity

Targeted Modification of Gut Microbiota and Related Metabolites Via Dietary Fiber

Assessing the Effects of Ginger Extract on Polyphenol Profiles and the Subsequent Impact on the Fecal Microbiota by Simulating Digestion and Fermentation In Vitro

Effects of a Galacto-Oligosaccharide-rich Diet on Fecal Microbiota and Metabolite Profiles in Mice.

Fermented Myriophyllum Aquaticum and Lactobacillus Plantarum Affect the Distribution of Intestinal Microbial Communities and Metabolic Profile in Mice

Pentagalloyl Glucose Regulated Probiotic and Metabolite SCFAs to Ameliorate Intestinal Barrier Integrity

Partially Hydrolyzed Guar Gum Intake Supports the Gut Microbiota and Attenuates Inflammation during Influenza H1N1 Virus Infection in Mice

In vitro assessment of the effect of four polysaccharides on intestinal bacteria of mice with colitis

Fecal fermentation behaviors of Konjac glucomannan and its impacts on human gut microbiota

Digestive characteristics of Gastrodia elata Blume polysaccharide and related impacts on human gut microbiota in vitro

Effect of konjac glucomannan on gut microbiota from hyperuricemia subjects in vitro: fermentation characteristics and inhibitory xanthine oxidase activity